The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement
- PMID: 18294803
- PMCID: PMC2614666
- DOI: 10.1016/j.jsat.2007.12.008
The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement
Abstract
Federal, state, and local government agencies require current and accurate cost information for publicly funded substance abuse treatment programs to guide program assessments and reimbursement decisions. The Center for Substance Abuse Treatment published a list of modality-specific cost bands for this purpose in 2002. However, the upper and lower values in these ranges are so wide that they offer little practical guidance for funding agencies. Thus, the dual purpose of this investigation was to assemble the most current and comprehensive set of economic cost estimates from the readily available literature and then use these estimates to develop updated modality-specific cost bands for more reasonable reimbursement policies. Although cost estimates were scant for some modalities, the recommended cost bands are based on the best available economic research, and we believe that these new ranges will be more useful to and pertinent for all stakeholders of publicly funded substance abuse treatment.
Similar articles
-
Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.Soc Sci Med. 2002 Dec;55(12):2267-82. doi: 10.1016/s0277-9536(02)00060-6. Soc Sci Med. 2002. PMID: 12409139
-
A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP).J Subst Abuse Treat. 1997 Sep-Oct;14(5):445-55. doi: 10.1016/s0740-5472(97)00132-3. J Subst Abuse Treat. 1997. PMID: 9437614
-
Organizational and client determinants of cost in outpatient substance abuse treatment.J Ment Health Policy Econ. 2007 Mar;10(1):3-13. J Ment Health Policy Econ. 2007. PMID: 17417043
-
Financing strategies for drug abuse treatment programs.J Subst Abuse Treat. 1995 Nov-Dec;12(6):385-99. doi: 10.1016/0740-5472(95)02012-8. J Subst Abuse Treat. 1995. PMID: 8749723 Review.
-
Impact of federal Substance Abuse Block Grants on state substance abuse spending: literature and data review.J Ment Health Policy Econ. 2003 Dec;6(4):173-9. J Ment Health Policy Econ. 2003. PMID: 14713724 Review.
Cited by
-
Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.Am J Law Med. 2012;38(4):607-66. doi: 10.1177/009885881203800402. Am J Law Med. 2012. PMID: 23356098 Free PMC article.
-
Net Benefits of Recovery High Schools: Higher Cost but Increased Sobriety and Educational Attainment.J Ment Health Policy Econ. 2019 Sep 1;22(3):109-120. J Ment Health Policy Econ. 2019. PMID: 31811754 Free PMC article.
-
Optimizing a community-engaged multi-level group intervention to reduce substance use: an application of the multiphase optimization strategy.Trials. 2018 Apr 27;19(1):255. doi: 10.1186/s13063-018-2624-5. Trials. 2018. PMID: 29703237 Free PMC article.
-
Monetary conversion factors for economic evaluations of substance use disorders.J Subst Abuse Treat. 2017 Oct;81:25-34. doi: 10.1016/j.jsat.2017.07.008. Epub 2017 Jul 18. J Subst Abuse Treat. 2017. PMID: 28847452 Free PMC article.
-
Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews.Subst Abuse. 2022 Aug 29;16:11782218221118462. doi: 10.1177/11782218221118462. eCollection 2022. Subst Abuse. 2022. PMID: 36062252 Free PMC article. Review.
References
-
- Alterman AI, O’Brien CP, McLellan AT, August DS, Snider EC, Droba M, et al. Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation. The Journal of Nervous and Mental Disease. 1994;182:157–163. - PubMed
-
- Anderson DW, Bowland BJ, Cartwright WS, Bassin G. Service-level costing of drug abuse treatment. Journal of Substance Abuse Treatment. 1998;15:201–211. - PubMed
-
- Avants SK, Margolin A, Sindelar JL, Rounsaville BJ, Schottenfeld R, Stine S, et al. Day treatment versus enhanced standard methadone services for opioid-dependent patients: A comparison of clinical efficacy and cost. American Journal of Psychiatry. 1999;156:27–33. - PubMed
-
- Beaston-Blaakman A, Shepard D, Horgan C, Ritter G. Organizational and client determinants of cost in outpatient substance abuse treatment. The Journal of Mental Health Policy and Economics. 2007;10:3–13. - PubMed